Key Notes According to two sources briefed on the situation, the parent company of PharmEasy, API Holdings, increased the size of its rights issuance from Rs 2,000-2,400 crore ($250-290 million)…
People familiar with PharmEasy 's most recent financials claim that the online pharmacy had a positive ebitda in April of about Rs 14 crore for the first time since its…
PharmEasy 's founders informed the Board earlier this month that they will not sell Thyrocare, the company's diagnostic division. The move comes as the e-pharmacy struggles to raise new funds…
API Holdings, which owns PharmEasy and is planning an IPO, intends to become profitable on an Ebitda basis in the next 4-5 quarters, CEO Siddharth Shah said shareholders at the…
Pharmeasy Rights Issue details Issue Size: 750 Crores Rights Entitlement Ratio: 1 CCPS for every 82 Shares held Record Date: September 9, 2022 Issue Price: ₹100 /- per CCPS (Premium…
PharmEasy (API Holdings Ltd) Proposed issuance Notice under the shareholders agreement for rights issue CCPS 1. Withdrawal of DRHP: the Company is desirous of undertaking a capital raise. Due to…
The pharmaceutical sector has always been as chaotic as we can imagine. Though we were all pleased with the wholesale and retail market structures provided by the pharmaceutical sector, the…
PharmEasy is in talks with investors to raise $200 million, but at a value that might be 15% or even 25% lower than last year's $5.1 billion, according to two…
Share of API holdings (Pharmeasy) became available in the unlisted markets at around 100/sh around 4-5 months back. A lot of investors had invested at around 110+ levels. Since then…